Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

The Medicare start-up is up double digits on no company-specific news.

Why Is Clover Health Soaring Today?

NASHVILLE, Tenn., April 28, 2021 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), an innovative technology company improving health outcomes for America's seniors, today announced that it will report first quarter 2021 financial results prior to market open on Monday, May 17, 2021. Management will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the company's business and financial results.

Clover Health to Report First Quarter 2021 Financial Results on May 17, 2021

Clover Health is a great game for speculators and great entertainment for the rest of us. It will take months to know CLOV stock's true value.

Can Clover Health Make a Case That It's More Than Just Speculation Fodder?

Clover Health is using AI and data analytics to disrupt the health insurance industry. The company has had blockbuster results in 2020 The post Clover Health Is Poised to Revolutionize Health Insurance, Ignore Negative Sentiment appeared first on InvestorPlace.

Clover Health Is Poised to Revolutionize Health Insurance, Ignore Negative Sentiment

Many traders are betting against this disruptor in the $270 billion Medicare Advantage market.

Will Clover Health Become The Next Legendary Short Squeeze After GameStop?

Fisker Inc

Social Capital Hedosophia Holdings Corp. V

Are these beaten-down SPACs ripe for a short squeeze?

3 SPACs That Short-Sellers Are Targeting

Hyliion

Nuuve

Investors aren't guaranteed an out at $10 on the price chart, but these sub $10 SPACs look primed for stronger weeks ahead. The post 3 SPACs Below $10 to Buy appeared first on InvestorPlace.

3 SPACs Below $10 to Buy

C3.ai

Blink Charging

Carvana

Discovery

Root

Support.com

For these seven short-squeeze stocks, a little bit of positive news may be enough to send them soaring to higher prices. The post 7 Short-Squeeze Targets to Watch This Week appeared first on InvestorPlace.

7 Short-Squeeze Targets to Watch This Week

Clover Health Investments Corp (NASDAQ:CLOV) is up 28% from Wednesday's close due to three factors that are aligning: News: Clover Health has become a top target in the r/WallStreetBets Reddit community.

Clover Health Stock Options Traders Are Betting It's Going Higher

As accusations fly and short-squeeze talk hits Wall Street, CLOV stock is just too hot to handle. Avoid Clover Health for now.

Let the Dust Settle Before Taking a Position in Clover Health

An apparent short squeeze in Clover Health Investments Corp (NASDAQ: CLOV) continued Monday despite the stock apparently having a much smaller short interest than some traders believed last week. On Thursday, Benzinga covered a report by S3 Partners in which S3 ranked several of the most heavily shorted stocks in the market by their short percent of float.

Clover Health Rally Continues Despite Confusion Over Short Interest

On April 16, a number of financial media outlets reported on the apparent explosive increase of the short interest in Clover Health Investments Corp. ( CLOV ), potentially setting the stage for a short squeeze akin to those that burned investors with bearish bets on GameStop Corp. ( GME ) and AMC Entertainment Holdings Inc. ( AMC ) earlier this year.

Clover Health: Short Squeeze Fears Look Overblown

The stock price of Clover Health Investments Corp (NASDAQ: CLOV) increased by over 14% pre-market. This is why it happened.

CLOV Stock: Over 14% Increase Pre-Market Explanation

CLOV stock has followed the traditional SPAC boom-and-bust cycle. However, it's still not low enough to call it a viable investment.

Clover Health Investments Isn't a Long-Term Stock Despite Proof of Concept

Clover Health Investments Corp (NASDAQ: CLOV) has popped up on the list of top trending stocks on r/WallStreetBets, the Reddit forum that conducted a short squeeze in shares of GameStop Corp (NYSE: GME) earlier in the year.  What Happened: Shares of the Chamath Palihapitiya-backed health technology company closed 20% higher at $8.82 on Friday and rose another 2.38% in the after-hours trading to $9.03.

Clover Health Joins Top WallStreetBets Stocks: What's Going On?

The digital health start-up's participation in a new Medicare program could be a very big deal.

Can Clover Health Double Your Money?

Could this be the next Reddit short-squeeze target?

Here's Why Clover Health Stock Soared Today

Crowded short trades have been punished repeatedly over the past few months. From GameStop Corp. (NYSE:GME) to AMC Entertainment Holdings Inc. (NYSE:AMC) , bearish investors have too often found themselves on the receiving end of a painful short squeeze.

Clover Health: The Next Stock to Get the GameStop Treatment?

The stock price of Clover Health Investments Corp (NASDAQ: CLOV) increased by over 35% during intraday trading. This is why it happened.

CLOV Stock: Over 35% Increase Intraday Explanation

Clover Health (CLOV) stock is on the rise Friday as retail traders online discuss the company's potential for a short squeeze. The post CLOV Stock: Clover Health Gets Some Short-Squeeze Juice appeared first on InvestorPlace.

CLOV Stock: Clover Health Gets Some Short-Squeeze Juice

Chamath Palihapitiya's Clover Health surged as much as 36% on Friday after adding former Trump official Demetrios Kouzoukas to its board of directors. Kouzoukas served as director of the Center for Medicare and the principal deputy administrator of the Centers for Medicare & Medicaid Services (CMS) for the last four years during the Trump administration.

Chamath Palihapitiya-backed Clover Health surges 36% after adding former Trump official to its board of directors (CLOV)

S3 Partners, an analytics firm that specializes in reporting market data, said in a report this week that Clover Health (NASDAQ: CLOV) has a high short percent of float of 144.73%, which caught the attention of many retail traders on Twitter and Reddit. Since GameStop's (NYSE: GME) insane run in January, many investors have been trying to find the next short squeeze.

Why Clover Health Could See A Big Short Squeeze

Clover Health operates in an expanding market, and the recent correction in share price warrants an investigation of a possible opportunity to gain exposure to the Medicare Advantage market. After closer examination, the share price seems fully valued, considering historical growth rate and peer comparisons.

Investors Unlikely To See Sharp Rebound In Clover Health Shares

Amazon

Okta

Put that stimulus money to work with these stocks.

Got $1,000? Here Are 3 Stocks to Buy in April

Levi Strauss

WD-40

Amazon, WD-40 Company, Levi and Clovis Health were our top stock trades for Monday. Let's get a look at the charts now.

News for Clover Health Investments Stock (CLOV)